Regular people are starting to trade like institutional traders - and they're making a living doing it. But not everyone is successful with their trades. There is a right way and a wrong way. I'm here to help you come up with vetted trade ideas so you actually make money off your trading.
Resilient Trader
Resilient Trader is where smart traders come for vetted ideas.
Every week, we cut through the noise and surface opportunities that institutions are already eyeing, but with strategies tailored for retail traders. Today's setup? The biggest name in off-price retail just bounced 15% in four weeks, straight back into the price where it gapped down on its last earnings report. Its closest rival's same-store sales are growing ten times faster, and 22 analysts still rate it a Buy.
We'll cover:
Why TJX Companies is a Short at $141.50 or better
Why the off-price boom has turned into an off-price price war
How one defined-risk put spread plays the November earnings report
🔍 Trade Thesis: Off-Price Is Now Eating Itself
For two decades the off-price trade was simple. Department stores shrank, and T.J. Maxx, Marshalls, Ross and Burlington took their customers. That well is running dry. With the department store base this small, the off-price chains are now taking share from each other, and right now TJX is the one losing.
Behind the scenes:
🏬 The 9-point gap: in the same summer quarter, Ross Stores comped +10% while Marmaxx (T.J. Maxx and Marshalls, TJX's biggest division) comped just +1%. Burlington managed +2%.
📉 Below plan, by management's own words: Marmaxx missed its own plan and management called the problem "self-inflicted" merchandise mix and execution.
🏷️ The fix costs margin: the fastest way to win shoppers back is sharper prices and deeper markdowns, and that comes straight out of profit over the next two quarters.
🧾 The tariff tailwind is a one-off: Q2 included $331 million of tariff refunds, which flattered the quarter and will not repeat.
$$TJX ( ▲ 0.86% ) trades at about 26 times earnings with a consensus target 20% above the price, so the Street is still priced for the old story. An institutional research desk we follow has the stock on its short list with a top-five "most actionable" tag, and its plan was to short it from the top of the range. This bounce delivered exactly that.
The honest bear case: management said Q3 "started strong" and guided comps to +2% to +3%. TJX is a low-beta (0.56) store chain that shoppers trade down to when money is tight, and only 1.7% of the float is sold short. The desk has not repeated the call since October 8, so we keep this on a short leash.
📊 Overview & Key Metrics
Metric | Figure |
|---|---|
Current Price | $141.53 |
Market Cap | $155.7 billion |
Trailing P/E | About 26 |
Q2 Net Sales | $15.2 billion (+5%) |
Q2 Comps: Total / Marmaxx | +4% / +1% |
Q2 Comps: Ross / Burlington | +10% / +2% |
Q3 Comp Guidance | +2% to +3% |
FY27 Adj. EPS Guidance | $5.15 to $5.20 |
52-Week Range | $122.78 to $170.00 |
Analyst Consensus | Buy (22 analysts), $170.80 average target |
📡 Market Sentiment & Fundamental Drivers
The total company still looks fine: sales rose 5%, HomeGoods comped +7%, and International +7%. That is why the Street stays bullish. But Marmaxx is the engine, and the engine sputtered while a direct rival hit double-digit comps for a second straight quarter.
Ross is not slowing down either. It guided its own Q3 comps to +6% to +7% and raised its store-opening plan. Every point of comp Ross wins comes from the same shopper TJX needs. Meanwhile the bigger tape is turning against consumer names: the research desk we follow is short consumer discretionary against long healthcare, and sees slowing growth for most of 2027.
📐 Technical Analysis
TJX gapped down from about $151 to $144 on its August 19 earnings report and kept falling to $122.84 on September 16. Since then it has rallied 15% straight back up, and on October 13 it touched $144.04, right at the price where the August gap opened, before fading.
Moving Averages:
✅ Below the 200-day at $151.97, so the primary trend is still down
✅ Just above the 50-day at $138.28, a level that capped the stock in August
✅ Stretched above the 20-day at $133.27, about 6% over it after a fast bounce
✅ RSI near 66, close to overbought for a stock in a downtrend
Key Levels:
Resistance: $144 (the August 19 gap open and the October 13 high), then $151
Support: $133 (the 20-day), then $122.84 (the September 16 closing low)
The Setup: a downtrend, a relief rally into the gap, and a print five weeks away. We short near the top of the bounce with a tight line just above it.
🧠 SWOT & Who Should Take This Trade
Strengths: the largest off-price buying operation in the world, a 30% return on invested capital, and steady buybacks.
Weaknesses: Marmaxx comps of +1% while a rival does +10%, and a premium multiple for a company growing sales 5%.
Opportunities (for the short): a weak Q3 Marmaxx number, a cautious holiday guide, and markdowns that squeeze margins.
Threats (to the short): a trade-down wave that lifts every discounter, and a management team that fixes its own mistakes quickly.
Who should take this: traders comfortable shorting a quality company on a rate-of-change story, with defined risk and a hard stop.
💥 Trade of the Week: Short the Bounce Into the Gap
🔴 Stock Trade
Short $$TJX ( ▲ 0.86% ) at $141.50 or better
🛡️ Options Play: Buy the December 18, 2026 $140/$125 Put Spread
Buy the Dec. 18, 2026 $140 Put
Sell the Dec. 18, 2026 $125 Put
Net debit: $4.10 or better ($410 per contract)
Why this structure: earnings in November are a binary event, so this is defined risk only. Selling the $125 put, right at our target, cuts the cost by about 24%. December 18 is the shortest monthly expiry that gives the expected November 18 report a month to play out; January costs more for weeks we do not need. (Prices and option quotes as of the October 13 close - verify with live brokerage prices.)
Risk-Reward Breakdown - Dec. 18, 2026 $140/$125 Put Spread
Item | Figure |
|---|---|
Net Debit | $4.10 per share ($410 per contract) |
Max Risk | $410 per contract |
Max Reward | $10.90 per share ($1,090 per contract) |
Breakeven | $135.90 |
Return on Risk | 266% at $125 or below |
Days to Expiration | 65 |
Payoff Table - Dec. 18, 2026 $140/$125 Put Spread
TJX at Expiration | Spread Value | Profit / Loss | Return |
|---|---|---|---|
$145.00 | $0.00 | -$410 | -100% (Stop) |
$141.50 | $0.00 | -$410 | -100% (Entry) |
$138.28 | $1.72 | -$238 | -58% (50-Day) |
$135.90 | $4.10 | $0 | 0% (Breakeven) |
$133.00 | $7.00 | +$290 | +71% (20-Day) |
$130.00 | $10.00 | +$590 | +144% |
$125.00 | $15.00 | +$1,090 | +266% (Max Gain) |
$122.84 | $15.00 | +$1,090 | +266% (Sept. Low) |
How it works: you own the right to sell TJX at $140 and have sold someone the right to sell it to you at $125. Every dollar TJX falls between those strikes is yours, and your entire risk is the $410 you pay up front. The stock only has to drop about 4% to break even, and it closed below that level just over a week ago.
🛑 Risk Management Tip
On the shares, a decisive close above $145 is the hard risk line. That is above the August gap open and the October 13 high, about 2.5% from our entry, and it means the market has filled the gap and the bounce is real. Size at 1% to 2% of your account. Short sellers also owe the dividend (about $0.48 a share) if they hold through the November 12 ex-dividend date. On the spread your risk is capped, so buy only what you can afford to lose.
🚀 Catalysts to Watch
1. Retail Sales (Thursday, October 15) - a fresh read on how hard the consumer is pulling back.
2. Ex-Dividend Date (November 12) - a cost to share shorts, not to the put spread.
3. TJX Q3 Earnings (expected Wednesday, November 18, before the open; not yet confirmed by the company) - the Marmaxx comp and the holiday guide are the whole trade.
4. Ross and Burlington Q3 Reports (late November) - if Ross keeps comping near double digits, the share-shift story gets louder.
5. Black Friday (November 27) - early holiday traffic and markdown chatter across off-price.
Enroll in Options Trading in 21 Days and get the full framework.
🧠 Final Thoughts
TJX is a great company. That is not the question. The question is whether a stock priced for steady share gains deserves that multiple while its biggest division comps +1% and its closest rival comps +10%.
We think the answer shows up in the November report. $$TJX ( ▲ 0.86% ) just rallied straight back into the price where it broke down in August, which gives us a clean entry with a tight, obvious stop.
If the stock closes above $145, we were early and we step aside. If Marmaxx stays soft, the September low is the first stop.
✅ Short TJX at $141.50 or better
💸 Buy the Dec. 18, 2026 $140/$125 put spread for a $4.10 net debit
Want more trade ideas like this - plus weekly options plays and breakdowns?
👉 Join the Paid Resilient Trader Newsletter
For more in-depth trading strategies and market insights, upgrade to the paid version of our newsletter.
Our paid newsletter gives you:
Weekly stock + options trade ideas
Market commentary and macro insights
Easy-to-follow setups with defined risk
Stay Liquid, my friends
- The Resilient Trader
Disclaimer: This publication is for educational purposes only and is not investment advice. Options involve risk and are not suitable for all investors. Do your own research and consider consulting a licensed financial professional.
💌 P.S. Want this in your inbox every week?
Subscribe to the Resilient Trader Free Newsletter
